1. Wareing, M.D., Marsh, G.A., and Tannock, G.A., Preparation and characterization of attenuated cold-adapted influenza a reassortants derived from the A/Leningrad/134/17/57 donor strain, Vaccine, 2002, vol. 20, no. 16, pp. 2082–2090.
2. Klimov, A. and Cox, N.J., PCR restriction analysis of genome composition and stability of cold-adapted reassortants live influenza vaccines, J. Virol. Methods, 1995, vol. 52, nos. 1–2, pp. 41–49.
3. Kiseleva, I.V., Voeten, J.T.M., Teley, L.C.P., Larionova, N.V., Dubrovina, I.A., Berdygulova, Zh.A., et al., Genome composition analysis of reassortant influenza viruses used in seasonal and pandemic live attenuated influenza vaccine, Mol. Gen. Microbiol. Virol, 2011, vol. 4, pp. 29–36.
4. WHO Manual on Animal Influenza Diagnosis and Surveillance, 2002. http://www.who.int/csr/resources/publications/influenza/whocdscsrncs20025rev.pdf . Cited August 1, 2013.
5. WHO Recommendations on the Composition of Influenza Virus Vaccines, 2013. http://www.who.int/influenza/vaccines/virus/recommendations/en/index.html . Cited August 1, 2013.